MedTech News
.................... by Andrew Celentano
New antivirals are being tested for herpesviruses, and scientists now know how they work
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.
Naturally occurring molecule shown to restore memory function in Alzheimer’s models
Cclcium alpha-ketoglutarate (CaAKG), a safe, naturally occurring metabolite commonly studied for healthy aging, can restore key memory-related brain functions that have been disrupted in Alzheimer’s disease.
New sprayable powder forms instant gel barrier to stop severe bleeding in seconds
A joint research team led by Professor Steve Park from the Department of Materials Science and Engineering and Professor Sangyong Jon from the Department of Biological Sciences has developed a powder-type hemostatic agent that forms a powerful hydrogel barrier.
The largest medtech funding rounds of 2025
As another year winds down, it’s safe to say that investment in medtech is not stopping any time soon.
Scientists create 4D ultrasound
What if we could watch blood move through an entire organ in real time?
Researchers turn cancer resistance mutations into targets for new immunotherapies
One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant cells acquire mutations that enable them to survive and spread.
AI model predicts blood loss in liposuction
A newly developed artificial intelligence (AI) model is highly accurate in predicting blood loss in patients undergoing high-volume liposuction, reports a study in the Plastic and Reconstructive Surgery journal.
Alzheimer’s disease can be reversed in animal models to achieve full neurological recovery
Now, a research team from University Hospitals, Case Western Reserve University, and the Louis Stokes Cleveland VA Medical Center has challenged this long-held dogma in the field. They tested whether brains already badly afflicted with advanced AD could recover.